» Articles » PMID: 9672575

Lipid Screening in a Managed Care Population

Overview
Publisher Sage Publications
Specialty Public Health
Date 1998 Dec 16
PMID 9672575
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the proportion of patients in a managed care setting who were screened and followed up for high blood cholesterol in accordance with the guidelines from the second report of the National Cholesterol Education Program-Adult Treatment Panel II.

Methods: The authors conducted a retrospective review of the medical records of 1004 health plan members ages 40-64 who had been continuously enrolled over a period of five years at one of three Prudential Health-Care sites.

Results: Eighty-four percent of patients in the study group had at least one total blood cholesterol level recorded in their medical records; a high density lipoprotein level was recorded for 67%. Cholesterol screening was highest among patients with a diagnosis of hypercholesterolemia (98%), hypertension (96%), or diabetes (94%) and among patients ages 60-64 (94%). Cholesterol screening did not vary by smoking status. More than 86% of those with a diagnosis of hypercholesterolemia were given dietary counseling, medication, or both.

Conclusions: Compliance with national guidelines in this setting exceeded the Year 2000 goals for lipid management and was comparable with compliance reported in other settings. Routine surveillance of prevention efforts can be a useful way to assess quality of medical care in managed care organizations.

Citing Articles

Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.

Moshayoff V, Faktor O, Laghi L, Celesti G, Peretz T, Keret D PLoS One. 2016; 11(7):e0159522.

PMID: 27441409 PMC: 4956030. DOI: 10.1371/journal.pone.0159522.


Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer.

Salehi R, Atapour N, Vatandoust N, Farahani N, Ahangari F, Salehi A Adv Biomed Res. 2016; 4:252.

PMID: 26918234 PMC: 4746937. DOI: 10.4103/2277-9175.170677.


Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay.

Grutzmann R, Molnar B, Pilarsky C, Habermann J, Schlag P, Saeger H PLoS One. 2008; 3(11):e3759.

PMID: 19018278 PMC: 2582436. DOI: 10.1371/journal.pone.0003759.


Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model.

Kim C, Hofer T, Kerr E J Gen Intern Med. 2003; 18(10):854-63.

PMID: 14521649 PMC: 1494935. DOI: 10.1046/j.1525-1497.2003.20910.x.

References
1.
Walsh J, Baron R, Browner W . Predictors of screening for hypercholesterolemia in a general internal medicine practice. West J Med. 1993; 158(4):359-63. PMC: 1022061. View

2.
Sempos C, Cleeman J, CARROLL M, Johnson C, Bachorik P, Gordon D . Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA. 1993; 269(23):3009-14. DOI: 10.1001/jama.269.23.3009. View

3.
Hulley S, Newman T, Grady D, Garber A, Baron R, Browner W . Should we be measuring blood cholesterol levels in young adults?. JAMA. 1993; 269(11):1416-9. View

4.
Giles W, Anda R, Jones D, Serdula M, Merritt R, DeStefano F . Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities. JAMA. 1993; 269(9):1133-8. View

5.
Robinson M, DeHaven M, Wallace J, Fost T . Hypercholesterolemia: case finding in family practice. South Med J. 1992; 85(11):1091-5. View